Accurate Assessment of β-Cell Function: The Hyperbolic Correction

Only in the last decade did modeling studies predict, and knockout experiments confirm, that type 2 diabetes is a "2-hit" disease in which insulin resistance is necessarily accompanied by beta-cell defect(s) preventing the compensatory upregulation of insulin secretion. This long- delayed insight was associated with the development of a constant, the "disposition index," describing the beta-cell sensitivity-secretion relationship as a rectangular hyperbola. Shifts in insulin sensitivity are accompanied by compensatory alterations in beta-cell sensitivity to glucose. Insulin-sensitive subjects do not require a massive insulin response to exogenous glucose to maintain a normal blood glucose. But if their insulin sensitivity decreases by 80%, as in late pregnancy, they need a fivefold greater insulin response to achieve an identical disposition index. Women with gestational diabetes have an insulin response similar to that of normal volunteers; at first glance, this suggests similar islet function, but the utility of the disposition index is to normalize this response to the amplitude of third trimester insulin resistance, revealing severe beta-cell deficiency. The index is a quantitative, convenient, and accurate tool in analyzing epidemiologic data and identifying incipient impaired glucose tolerance. Separate major issues remain, however: the causes of insulin resistance, the causes of the failure of adequate beta-cell compensation in type 2 diabetes, and the nature of the signal(s) from insulin-resistant tissues that fail to elicit the appropriate beta-cell increment in sensitivity to glucose and other stimuli. The disposition index is likely to remain the most accurate physiologic measure for testing hypotheses and solutions to these challenges in whole organisms.

[1]  B. Ahrén,et al.  Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance , 1996, Diabetologia.

[2]  T. R. Hennessy,et al.  Measurement of glucose metabolism and insulin secretion during normal pregnancy and pregnancy complicated by gestational diabetes , 1996, Diabetologia.

[3]  P. Arner,et al.  Different aetiologies of Type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects , 1991, Diabetologia.

[4]  T. Buchanan Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. , 2001, The Journal of clinical endocrinology and metabolism.

[5]  R. Kulkarni,et al.  A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. , 2000, Diabetes.

[6]  R. Bergman,et al.  Longitudinal Compensation for Fat-induced Insulin Resistance Includes Reduced Insulin Clearance and Enhanced ␤-cell Response Research Design and Methods , 2022 .

[7]  R. Bergman,et al.  Free Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus , 2000, Trends in Endocrinology & Metabolism.

[8]  T. Valle,et al.  The Finnish Diabetes Prevention Study , 2000, British Journal of Nutrition.

[9]  T. Buchanan,et al.  Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. , 2000, Diabetes.

[10]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[11]  C. Bogardus,et al.  Long-term changes in insulin action and insulin secretion associated with gain, loss, regain and maintenance of body weight , 2000, Diabetologia.

[12]  S. Woods,et al.  Reduced beta-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. , 1999, The American journal of physiology.

[13]  S. Woods,et al.  Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. , 1999, American journal of physiology. Endocrinology and metabolism.

[14]  T. Buchanan,et al.  Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes. , 1999, Diabetes.

[15]  S. Kahn,et al.  Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. , 1999, The Journal of clinical endocrinology and metabolism.

[16]  D. Harrison,et al.  The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. , 1999, Diabetes.

[17]  G. Boden,et al.  Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. , 1999, Diabetes.

[18]  J. McGarry,et al.  Fatty acids, lipotoxicity and insulin secretion , 1999, Diabetologia.

[19]  Y. Kido,et al.  Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue , 1998, Nature Genetics.

[20]  G. Pacini,et al.  PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. , 1998, American journal of physiology. Endocrinology and metabolism.

[21]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[22]  G. Pacini,et al.  Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance. , 1997, The American journal of physiology.

[23]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[24]  R. Bergman,et al.  Insulin Sensitivity and Acute Insulin Response in African-Americans, Non-Hispanic Whites, and Hispanics With NIDDM: The Insulin Resistance Atherosclerosis Study , 1997, Diabetes.

[25]  A. Rocchini,et al.  Time course of insulin resistance associated with feeding dogs a high-fat diet. , 1997, The American journal of physiology.

[26]  J. McGarry,et al.  Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. , 1996, The Journal of clinical investigation.

[27]  R. Bergman,et al.  The insulin resistance atherosclerosis study (IRAS) objectives, design, and recruitment results. , 1995, Annals of epidemiology.

[28]  G. Boden,et al.  Effects of a 48-h Fat Infusion on Insulin Secretion and Glucose Utilization , 1995, Diabetes.

[29]  J. H. Johnson,et al.  Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Rossetti,et al.  Mechanisms of fatty acid-induced inhibition of glucose uptake. , 1994, The Journal of clinical investigation.

[31]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[32]  K. Tokuyama,et al.  Pathogenic Factors Responsible for Glucose Intolerance in Patients With NIDDM , 1992, Diabetes.

[33]  H. Lebovitz,et al.  Patterns of Glucose and Lipid Abnormalities in Black NIDDM Subjects , 1991, Diabetes Care.

[34]  R. Bergman Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[35]  R. Bergman,et al.  Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. , 1985, The Journal of clinical endocrinology and metabolism.

[36]  R. DeFronzo,et al.  Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.

[37]  Claudio Cobelli,et al.  Physiologic Evaluation of Factors Controlling , 1981 .

[38]  N. Freinkel,et al.  Banting Lecture 1980: of Pregnancy and Progeny , 1980, Diabetes.

[39]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.

[40]  G. Reaven,et al.  Study of the Relationship Between Glucose and Insulin Responses to an Oral Glucose Load in Man , 1968, Diabetes.